Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020
Medical Devices sector report, Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Pancreatic Cancer Diagnostic Tests include assays of mostly antibodies released in response to a pancreatic cancer and cancer-causing proteins.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Pancreatic Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Pancreatic Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
2 Introduction
2.1 Pancreatic Cancer Overview
3 Products under Development
3.1 Pancreatic Cancer - Pipeline Products by Stage of Development
3.2 Pancreatic Cancer - Pipeline Products by Territory
3.3 Pancreatic Cancer - Pipeline Products by Regulatory Path
3.4 Pancreatic Cancer - Pipeline Products by Estimated Approval Date
3.5 Pancreatic Cancer - Ongoing Clinical Trials
4 Pancreatic Cancer - Pipeline Products under Development by Companies
4.1 Pancreatic Cancer Companies - Pipeline Products by Stage of Development
4.2 Pancreatic Cancer - Pipeline Products by Stage of Development
5 Pancreatic Cancer Companies and Product Overview
6 Pancreatic Cancer- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List Of Tables
Table 1: Pancreatic Cancer - Pipeline Products by Stage of Development
Table 2: Pancreatic Cancer - Pipeline Products by Territory
Table 3: Pancreatic Cancer - Pipeline Products by Regulatory Path
Table 4: Pancreatic Cancer - Pipeline Products by Estimated Approval Date
Table 5: Pancreatic Cancer - Ongoing Clinical Trials
Table 6: Pancreatic Cancer Companies - Pipeline Products by Stage of Development
Table 7: Pancreatic Cancer - Pipeline Products by Stage of Development
Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview
Table 9: IndiTreat - PC - Product Status
Table 10: IndiTreat - PC - Product Description
Table 11: 2cureX AB - Ongoing Clinical Trials Overview
Table 12: IndiTreat - PC - Predictive Value of In-vitro Anti-cancer Therapy Sensitivity Testing on Tumoroids from Patients with Metastatic Pancreatic Cancer
Table 13: 3rd Street Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Diagnostic Test Kit - Pancreatic Ductal Adenocarcinoma - Product Status
Table 15: Diagnostic Test Kit - Pancreatic Ductal Adenocarcinoma - Product Description
Table 16: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Companion Diagnostic Test - Pancreatic Cancer - Product Status
Table 18: Companion Diagnostic Test - Pancreatic Cancer - Product Description
Table 19: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 21: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 22: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Companion Diagnostic Assay - Masitinib - Product Status
Table 24: Companion Diagnostic Assay - Masitinib - Product Description
Table 25: Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Status
Table 26: Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Description
Table 27: GemciTest - Product Status
Table 28: GemciTest - Product Description
Table 29: Acobiom - Ongoing Clinical Trials Overview
Table 30: GemciTest - Evaluation of GEMCITEST in Patients with Pancreatic Cancer and Treated by Chemotherapy (GEMCIPANC)
Table 31: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 32: PancreaDix - Product Status
Table 33: PancreaDix - Product Description
Table 34: Alaunus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 36: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 37: Amplified Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 38: PanCystPro - Product Status
Table 39: PanCystPro - Product Description
Table 40: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Cchek - Pancreatic Cancer Confirmatory Test - Product Status
Table 42: Cchek - Pancreatic Cancer Confirmatory Test - Product Description
Table 43: Cchek - Pancreatic Cancer Recurrence Test - Product Status
Table 44: Cchek - Pancreatic Cancer Recurrence Test - Product Description
Table 45: Cchek - Pancreatic Cancer Screening Test - Product Status
Table 46: Cchek - Pancreatic Cancer Screening Test - Product Description
Table 47: Cchek - Pancreatic Cancer Treatment Monitoring Test - Product Status
Table 48: Cchek - Pancreatic Cancer Treatment Monitoring Test - Product Description
Table 49: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
Table 50: Cchek - Pancreatic Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
Table 51: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
List Of Figures
Figure 1: Pancreatic Cancer - Pipeline Products by Stage of Development
Figure 2: Pancreatic Cancer - Pipeline Products by Territory
Figure 3: Pancreatic Cancer - Pipeline Products by Regulatory Path
Figure 4: Pancreatic Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Pancreatic Cancer - Ongoing Clinical Trials
Global Pancreatic Enzymes Market Research Report 2023-2027
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Pancreatic Enzymes Report by Material, Application, and Geography Global Forecast
USD 3200 View ReportBRIC Pancreatic and Biliary Stent Procedures Outlook to 2025 - Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures and Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures
BRIC Pancreatic and Biliary Stent Procedures Outlook to 2025 - Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures and Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting ProceduresIts BRIC Pancreatic and
USD 3995 View Report2023-2028 Vietnam Cancer Diagnostics Market
2023-2028 Vietnam Cancer Diagnostics Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers This unique report from provides information and analysis not
USD 950 View Report2023-2028 Venezuela Cancer Diagnostics Market
2023-2028 Venezuela Cancer Diagnostics Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers This unique report from provides information and analysis not
USD 950 View ReportFill The Form For Sample Request